1. Market Research
  2. > Life Sciences
Customer Support

Talk to Ahmad

+1 718 618 4302

About 6600 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Burkitt Lymphoma Global Clinical Trials Review, H2, 2020

  • $ 2500
  • August 2020
  • 243 pages

Autologous Transplantation And Stem Cell Based-gene Therapy For The Treatment Of HIV-associated Lymphoma [...] Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients with HIV-Associated Non-Hodgkin or Hodgkin Lymphoma [...] AIDS - Related Lymphoma, Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, Cutaneous B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Hairy Cell Leukemia, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Lymphoblastic Lymphoma, Lymphoma, Mantle Cell Lymphoma, Mycosis Fungoides, Natural Killer Cell Lymphomas, Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphomas (PTCL), Sezary Syndrome, T-Cell Lymphomas, Unspecified B-Cell Lymphomas, Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymph oma)

  • World
  • G7
  • Clinical Trial
  • Industry analysis
  • Stem Cell Transplantation

Lymphoma Treatment Drugs Markets in China

  • $ 4000
  • September 2020
  • 206 pages

Other Lymphoma Treatment Drugs [...] There are also many kinds of Other Lymphoma Treatment Drugs, but the total sales volume of these Other Lymphoma Treatment Drugs is a little small. [...] In 2019, the sales volume of other Lymphoma Treatment Drugs reached ## million yuan, accounting for ## % of the total Lymphoma Treatment Drugs sales volume.

  • China
  • Lymphoma
  • Industry analysis
  • Prescription Drug Sales
  • Industrial Production

Burkitt Lymphoma Global Clinical Trials Review, H1, 2020

  • $ 2500
  • February 2020
  • 311 pages

Clinical Trials by G7 Countries: Proportion of Burkitt Lymphoma to Oncology Clinical Trials [...] Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada and Japan) countries, The United States ha ve the highest proportion of Burkitt Lymphoma to Oncology clinical trials as of February 2020. [...] Proportion of Burkitt Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2020*

  • World
  • G7
  • Clinical Trial
  • Industry analysis
  • Stem Cell Transplantation

Follicular Lymphoma - Epidemiology Forecast to 2030

  • $ 3750
  • September 2020
  • 100 pages

‘Follicular Lymphoma - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical, and forecasted Follicular Lymphoma epidemiology in the 7MM, i.e., the United ...

  • United States
  • Japan
  • Lymphoma
  • Industry analysis

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2019

  • $ 2500
  • April 2019
  • 63 pages

Clinical Trials by G7 Countries: Proportion of Cutaneous B-Cell Lymphoma to Oncology Clinical Trials [...] Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada and Japan) countries, The United States have the highest proportion of Cutaneous B-Cell Lymphoma to Oncology clinical trials as of April 2019. [...] Proportion of Cutaneous B-Cell Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2019*

  • G7
  • APAC
  • Clinical Trial
  • Industry analysis

AIDS - Related Lymphoma Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018
  • 74 pages

Top Companies Participating in AIDS - Related Lymphoma Therapeutics Clinical Trials [...] As of October 2018, F. Hoffmann-La Roche Ltd sponsored the highest number of aids - related lymphoma clinical trials.

  • G7
  • APAC
  • Clinical Trial
  • Industry analysis
  • Stem Cell Transplantation

Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020

  • $ 2000
  • January 2020
  • 60 pages

"Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Indolent Lymphoma. The marketed ...

  • World
  • United States
  • Lymphoma
  • Industry analysis
  • Health Expenditure

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H2, 2018

  • $ 2500
  • October 2018
  • 284 pages

Top Companies Participating in Anaplastic Large Cell Lymphoma (ALCL) Therapeutics Clinical Trials [...] As of October 2018, Takeda Pharmaceutical Co Ltd sponsored the highest number of anaplastic large cell lymphoma (alcl) clinical trials.

  • G7
  • APAC
  • Clinical Trial
  • Industry analysis
  • Stem Cell Transplantation
  • Diagnostic Imaging Density

Global Mantle Cell Lymphoma Therapeutics Market 2019-2023

  • $ 2500
  • July 2019
  • 131 pages

Global Mantle Cell Lymphoma Therapeutics Market: About this market Mantle cell lymphoma therapeutics are available in combination therapy and monotherapy. This mantle cell lymphoma therapeutics market ...

  • World
  • Therapy
  • Lymphoma
  • Industry analysis

Global Follicular Lymphoma Therapeutics Market 2018-2022

  • $ 2500
  • October 2018
  • 105 pages

About Follicular Lymphoma Follicular lymphoma is a subtype of B-cell non-Hodgkin lymphoma (NHL). It is usually indolent (slow-growing) and the tumor cells grow as groups to form nodules. Symptoms of follicula ...

  • World
  • Lymphoma
  • Therapy
  • Industry analysis

2019 Burkitt Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 142 pages

The ongoing clinical trial research report- “2019 Burkitt Lymphoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Burkitt Lymphoma trials across the world. The report presents ...

  • World
  • APAC
  • Lymphoma
  • Clinical Trial
  • Industry analysis

2019 Follicular Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 413 pages

The ongoing clinical trial research report- “2019 Follicular Lymphoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Follicular Lymphoma trials across the world. The report ...

  • World
  • APAC
  • Lymphoma
  • Clinical Trial
  • Industry analysis

2019 Lymphoblastic Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 150 pages

The ongoing clinical trial research report- “2019 Lymphoblastic Lymphoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Lymphoblastic Lymphoma trials across the world. The ...

  • World
  • APAC
  • Clinical Trial
  • Lymphoma
  • Industry analysis

2019 Lymphoplasmacytic Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 176 pages

The ongoing clinical trial research report- “2019 Lymphoplasmacytic Lymphoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Lymphoplasmacytic Lymphoma trials across the ...

  • World
  • APAC
  • Clinical Trial
  • Lymphoma
  • Industry analysis

2019 AIDS Related Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 45 pages

The ongoing clinical trial research report- “2019 AIDS Related Lymphoma Ongoing Clinical Trials Study” analyzes the current scenario of all active AIDS Related Lymphoma trials across the world. The ...

  • World
  • APAC
  • Lymphoma
  • Clinical Trial
  • Industry analysis

Global Burkitt Lymphoma Therapeutics Market 2018-2022

  • $ 2500
  • September 2018
  • 109 pages

About Burkitt Lymphoma Burkitt Lymphoma is one of the rare types of B-cell non-Hodgkin’s lymphoma. It constitutes about 1-2% of all types of non-Hodgkins lymphoma types. It progresses at a very high ...

  • World
  • Lymphoma
  • Industry analysis

2019 Cutaneous B-Cell Lymphoma Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 37 pages

The ongoing clinical trial research report- “2019 Cutaneous B-Cell Lymphoma Ongoing Clinical Trials Study” analyzes the current scenario of all active Cutaneous B-Cell Lymphoma trials across the world. ...

  • World
  • APAC
  • Lymphoma
  • Clinical Trial
  • Industry analysis

2019 Natural Killer Cell Lymphomas Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • February 2019
  • 112 pages

The ongoing clinical trial research report- “2019 Natural Killer Cell Lymphomas Ongoing Clinical Trials Study” analyzes the current scenario of all active Natural Killer Cell Lymphomas trials across ...

  • World
  • APAC
  • Cell Therapy
  • Clinical Trial
  • Industry analysis

Indolent Lymphoma R&D Pipeline Analysis Report, H2-2018

  • $ 2200
  • August 2018
  • 170 pages

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Indolent Lymphoma Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information ...

  • World
  • Lymphoma
  • Industry analysis

Burkitt Lymphoma R&D Pipeline Analysis Report, H2-2018

  • $ 2200
  • August 2018
  • 100 pages

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Burkitt Lymphoma Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of ...

  • World
  • Lymphoma
  • Industry analysis
View report >

Global Lymphoma and Therapy Market Trends

  • December 2019
  • 10 pages

Key Highlights points of Hodgkin Lymphoma Treatment Market 2019 : [...] • Competitive study of the major Hodgkin Lymphoma Treatment market players will help in analyzing the market driving and business strategies. [...] • An overview of the global market for Global Hodgkin Lymphoma Treatment Market and related technologies.

  • World
  • Lymphoma
  • Therapy
  • Industry analysis

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on